PA MedTech Venture Capital Fund

The MedTech Fund offers access to the Shifamed portfolio companies by predominantly
investing in current and newly created companies, all of which focus on attractive high growth markets such as cardiovascular, ophthalmology, digital health and AI.

These companies implement a fast-follower strategy to expedite value creation. Starting with a large, clearly defined unmet clinical need and a competitive landscape of promising first-generation platforms, Shifamed’s approach has the potential to deliver significant value to the market and investors by leveraging established regulatory and reimbursement pathways.

The development model, infrastructure, and depth of core competencies are designed for
speed and optimized for early exits, proven with six successful exits to strategic partners,
all with an expedited time to sale compared to industry average.

• Demographics
  Ageing population is leading to major structural growth for cardio-vascular and eye-related issues

• Market
  Making up 10% of global GDP, the healthcare sector is a huge market with enormous potential for optimization

• Digitisation
  The healthcare sector is at the start of its digitization journey and together with the increased use of sensors is set for rapid growth

• Impact
  With this investment you help to save lives and safeguard medical progress

• Returns
  Our fund targets three to five-fold returns for each opportunity in a five-year timeframe*

• Risk
  Our fund aims to minimize risk compared to standard venture capital investments

• 6 Exits out of 6, to strategic partners
• 4.7 x Solid steady returns on average
• De-risked opportunity compared to similar growth investments
• < 5Y Expeditated time to sale on average